Assessment of a strategy combining ambulatory blood pressure, adherence monitoring and a standardised triple therapy in resistant hypertension

被引:3
|
作者
Polychronopoulou, Erietta [1 ,2 ]
Burnier, Michel [1 ,2 ]
Ehret, Georg [3 ]
Schoenenberger-Berzins, Renate [4 ]
Berney, Maxime [1 ,2 ]
Ponte, Belen [5 ]
Erne, Paul [6 ]
Bochud, Murielle [7 ]
Pechere-Bertschi, Antoinette [5 ]
Wuerzner, Gregoire [1 ,2 ]
机构
[1] Lausanne Univ Hosp, Serv Nephrol & Hypertens, Lausanne, Switzerland
[2] Lausanne Univ, CHUV, Lausanne, Switzerland
[3] Geneva Univ Hosp, Cardiol, Geneva, Switzerland
[4] Luzerner Kantonspital, Herzzentrum, Luzern, Switzerland
[5] Univ Hosp, Serv Nephrol & Hypertens, Hypertens Ctr, Geneva, Switzerland
[6] Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland
[7] Univ Lausanne, Univ Ctr Gen Med & Publ Hlth, Unisante, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
Resistant hypertension; blood pressure control; fixed-dose combination therapy; electronic pill boxes; treatment adherence; MEDICATION ADHERENCE; PREVALENCE; HYDROCHLOROTHIAZIDE; ASSOCIATION; AMLODIPINE; MANAGEMENT; DIAGNOSIS; APPARENT;
D O I
10.1080/08037051.2021.1907174
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose Poor adherence to drug therapy and inadequate drug regimens are two frequent factors responsible for the poor blood pressure (BP) control observed in patients with apparent resistant hypertension. We evaluated the efficacy of an antihypertensive management strategy combining a standardised therapy with three long acting drugs and electronic monitoring of drug adherence in patients with apparent resistant hypertension. Materials and Methods In this multicentric observational study, adult patients with residual hypertension on 24 h ambulatory BP monitoring (ABMP) despite the use of three or more antihypertensive drugs could be included. Olmesartan/amlodipine (40/10 mg, single pill fixed-dose combination) and chlorthalidone (25 mg) were prescribed for 3 months in two separated electronic pills boxes (EPB). The primary outcome was 24 h ambulatory systolic BP (SBP) control at 3 months, defined as mean SBP Results We enrolled 48 patients (36.0% women) of whom 35 had complete EPB data. After 3 months, 52.1% of patients had 24 h SBP <130 mmHg. 24 h SBP decreased by respectively -9.1 +/- 15.5 mmHg, -22.8 +/- 30.6 mmHg and -27.7 +/- 16.6 mmHg from the tertile with the lowest adherence to the tertile with the highest adherence to the single pill combination (p = 0.024). A similar trend was observed with tertiles of adherence to chlorthalidone. Adherence superior to 90% was associated with 24 h systolic and diastolic blood pressure control in multiple logistic regression analysis (odds ratio = 14.1 (95% confidence interval 1.1-173.3, p = 0.039). Conclusions A simplified standardised antihypertensive therapy combined with electronic monitoring of adherence normalises SBP in about half of patients with apparent resistant hypertension. Such combined management strategy enables identifying patients who need complementary investigations and those who rather need a long-term support of their adherence.
引用
收藏
页码:332 / 340
页数:9
相关论文
共 50 条
  • [1] Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters?
    Cardoso, Claudia R. L.
    Salles, Gil F.
    CURRENT HYPERTENSION REPORTS, 2016, 18 (12)
  • [2] Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension
    Burnier, Michel
    Wuerzner, Gregoire
    SEMINARS IN NEPHROLOGY, 2014, 34 (05) : 498 - 505
  • [3] Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension
    Grassi, Guido
    Bombelli, Michele
    Seravalle, Gino
    Brambilla, Gianmaria
    Dell'Oro, Raffaella
    Mancia, Giuseppe
    CURRENT HYPERTENSION REPORTS, 2013, 15 (03) : 232 - 237
  • [4] How to use ambulatory blood pressure monitoring in resistant hypertension
    Muxfeldt, Elizabeth S.
    Salles, Gil F.
    HYPERTENSION RESEARCH, 2013, 36 (05) : 385 - 389
  • [5] Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension
    Guido Grassi
    Michele Bombelli
    Gino Seravalle
    Gianmaria Brambilla
    Raffaella Dell’Oro
    Giuseppe Mancia
    Current Hypertension Reports, 2013, 15 : 232 - 237
  • [6] Clinical characteristics of resistant hypertension evaluated by ambulatory blood pressure monitoring
    Kansui, Yasuo
    Matsumura, Kiyoshi
    Kida, Haruko
    Sakata, Satoko
    Ohtsubo, Toshio
    Ibaraki, Ai
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2014, 36 (07) : 454 - 458
  • [7] Role of home blood pressure monitoring in resistant hypertension
    Kim, Hyue Mee
    Shin, Jinho
    CLINICAL HYPERTENSION, 2023, 29 (01)
  • [8] Discrepancies between home blood pressure and ambulatory blood pressure monitoring in apparent treatment-resistant hypertension: analysis from the Korean resistant hypertension cohort
    Seo, Jiwon
    Lee, Chan Joo
    Kim, Dae-Hee
    Kim, Song-Yi
    Moon, Jae Youn
    Park, Jae-Hyeong
    Son, Jang-Won
    Kim, Jang Young
    Kim, In-Cheol
    Rhee, Moo-Yong
    Lee, Ju-Hee
    Lee, Hae-Young
    Chung, Joong-Wha
    Ihm, Sang-Hyun
    Choi, Jung Hyun
    Shin, Jinho
    Park, Sungha
    HYPERTENSION RESEARCH, 2025, 48 (01) : 37 - 48
  • [9] How to use ambulatory blood pressure monitoring in resistant hypertension
    Elizabeth S Muxfeldt
    Gil F Salles
    Hypertension Research, 2013, 36 : 385 - 389
  • [10] Profile of ambulatory blood pressure in resistant hypertension
    de la Sierra, Alejandro
    HYPERTENSION RESEARCH, 2013, 36 (07) : 565 - 569